NCT02608346View on ClinicalTrials.gov

Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

NACompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 29, 2021

Study Completion Date

December 29, 2021

Conditions

Women With BRCA1 Germline Deleterious Mutation

Interventions

PROCEDURE

Blood sampling

"Patients will have a blood draw at each visit to the hospital,~* with a maximum of 1 blood draw every 3 months, in absence of any abnormal clinical/radiological exam~* with a maximum of 1 blood draw every week, in case of abnormal clinical/radiological exam that requires further investigation"

Trial Locations (4)

69273

Centre Léon Bérard, Lyon

75005

Institut Curie, Paris

92210

Hôpital René Huguenin - Institut Curie, Saint-Cloud

94805

Institut Gustave ROUSSY, Villejuif

All Listed Sponsors

lead

Institut Curie

OTHER

NCT02608346 - Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01) | Biotech Hunter | Biotech Hunter